1. Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials. (28th March 2018) Authors: Nicolè, S; Lanzafame, M; Cucchetto, G; Rigo, F; Lattuada, E; Concia, E Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 6(2018) Page Start: 1728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV‐1‐infected patients. Issue 10 (15th May 2017) Authors: Rigo, F; Cucchetto, G; Lanzafame, M; Nicolè, S; Lattuada, E; Concia, E; Vento, S Journal: HIV medicine Issue: Volume 18:Issue 10(2017:Nov.) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗